Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:JEN - BE0003858751 - Common Stock

60 EUR
-0.6 (-0.99%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

7

Overall JEN gets a fundamental rating of 7 out of 10. We evaluated JEN against 114 industry peers in the Machinery industry. JEN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. JEN may be a bit undervalued, certainly considering the very reasonable score on growth This makes JEN very considerable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • JEN had positive earnings in the past year.
  • In the past year JEN had a positive cash flow from operations.
  • Each year in the past 5 years JEN has been profitable.
  • JEN had a positive operating cash flow in 4 of the past 5 years.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • JEN has a Return On Assets of 10.74%. This is amongst the best in the industry. JEN outperforms 89.47% of its industry peers.
  • JEN has a better Return On Equity (17.97%) than 81.58% of its industry peers.
  • The Return On Invested Capital of JEN (13.79%) is better than 87.72% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for JEN is in line with the industry average of 9.14%.
  • The last Return On Invested Capital (13.79%) for JEN is above the 3 year average (9.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.74%
ROE 17.97%
ROIC 13.79%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • JEN's Profit Margin of 10.63% is amongst the best of the industry. JEN outperforms 81.58% of its industry peers.
  • JEN's Profit Margin has improved in the last couple of years.
  • JEN's Operating Margin of 12.57% is fine compared to the rest of the industry. JEN outperforms 76.32% of its industry peers.
  • JEN's Operating Margin has improved in the last couple of years.
  • JEN has a worse Gross Margin (14.50%) than 92.98% of its industry peers.
  • JEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.57%
PM (TTM) 10.63%
GM 14.5%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JEN is creating value.
  • JEN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, JEN has more shares outstanding
  • The debt/assets ratio for JEN is higher compared to a year ago.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 4.15 indicates that JEN is not in any danger for bankruptcy at the moment.
  • JEN has a Altman-Z score of 4.15. This is amongst the best in the industry. JEN outperforms 80.70% of its industry peers.
  • JEN has a debt to FCF ratio of 1.11. This is a very positive value and a sign of high solvency as it would only need 1.11 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.11, JEN belongs to the best of the industry, outperforming 90.35% of the companies in the same industry.
  • A Debt/Equity ratio of 0.09 indicates that JEN is not too dependend on debt financing.
  • JEN has a Debt to Equity ratio of 0.09. This is amongst the best in the industry. JEN outperforms 85.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.11
Altman-Z 4.15
ROIC/WACC1.88
WACC7.34%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • JEN has a Current Ratio of 1.98. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
  • JEN has a better Current ratio (1.98) than 73.68% of its industry peers.
  • JEN has a Quick Ratio of 1.49. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.49, JEN belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.49
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

  • JEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.32%, which is quite impressive.
  • JEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.40% yearly.
  • JEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.22%.
  • The Revenue has been growing slightly by 6.41% on average over the past years.
EPS 1Y (TTM)46.32%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%51.85%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%15.76%

3.2 Future

  • JEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.01% yearly.
  • JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.68% yearly.
EPS Next Y42.92%
EPS Next 2Y23.28%
EPS Next 3Y16.35%
EPS Next 5Y5.01%
Revenue Next Year16.78%
Revenue Next 2Y9.42%
Revenue Next 3Y7.12%
Revenue Next 5Y3.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.91, which indicates a very decent valuation of JEN.
  • Compared to the rest of the industry, the Price/Earnings ratio of JEN indicates a rather cheap valuation: JEN is cheaper than 89.47% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, JEN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 8.65 indicates a reasonable valuation of JEN.
  • Based on the Price/Forward Earnings ratio, JEN is valued cheaper than 89.47% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.26. JEN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.91
Fwd PE 8.65
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 64.91% of the companies in the same industry are more expensive than JEN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, JEN is valued a bit cheaper than 67.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.53
EV/EBITDA 8.42
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of JEN may justify a higher PE ratio.
  • JEN's earnings are expected to grow with 16.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)0.67
EPS Next 2Y23.28%
EPS Next 3Y16.35%

3

5. Dividend

5.1 Amount

  • JEN has a Yearly Dividend Yield of 1.16%.
  • JEN's Dividend Yield is comparable with the industry average which is at 1.55.
  • Compared to the average S&P500 Dividend Yield of 1.89, JEN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

  • The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • JEN pays out 18.67% of its income as dividend. This is a sustainable payout ratio.
DP18.67%
EPS Next 2Y23.28%
EPS Next 3Y16.35%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JENSEN-GROUP NV

EBR:JEN (1/16/2026, 7:00:00 PM)

60

-0.6 (-0.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-05
Earnings (Next)03-05
Inst Owners7.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap577.80M
Revenue(TTM)488.99M
Net Income(TTM)51.98M
Analysts80
Price Target68.85 (14.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP18.67%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.16%
EPS NY rev (3m)2.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.38%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.91
Fwd PE 8.65
P/S 1.18
P/FCF 14.53
P/OCF 11.21
P/B 2
P/tB 2.44
EV/EBITDA 8.42
EPS(TTM)5.5
EY9.17%
EPS(NY)6.94
Fwd EY11.56%
FCF(TTM)4.13
FCFY6.88%
OCF(TTM)5.35
OCFY8.92%
SpS50.78
BVpS30.04
TBVpS24.59
PEG (NY)0.25
PEG (5Y)0.67
Graham Number60.97
Profitability
Industry RankSector Rank
ROA 10.74%
ROE 17.97%
ROCE 18.35%
ROIC 13.79%
ROICexc 15%
ROICexgc 18.08%
OM 12.57%
PM (TTM) 10.63%
GM 14.5%
FCFM 8.13%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
ROICexc(3y)11.13%
ROICexc(5y)10.46%
ROICexgc(3y)12.99%
ROICexgc(5y)12.14%
ROCE(3y)13.16%
ROCE(5y)11.32%
ROICexgc growth 3Y5.22%
ROICexgc growth 5Y2.88%
ROICexc growth 3Y5.28%
ROICexc growth 5Y0.03%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.11
Debt/EBITDA 0.38
Cap/Depr 118.83%
Cap/Sales 2.41%
Interest Coverage 35.71
Cash Conversion 72.22%
Profit Quality 76.51%
Current Ratio 1.98
Quick Ratio 1.49
Altman-Z 4.15
F-Score7
WACC7.34%
ROIC/WACC1.88
Cap/Depr(3y)117.95%
Cap/Depr(5y)108.4%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.32%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%51.85%
EPS Next Y42.92%
EPS Next 2Y23.28%
EPS Next 3Y16.35%
EPS Next 5Y5.01%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%15.76%
Revenue Next Year16.78%
Revenue Next 2Y9.42%
Revenue Next 3Y7.12%
Revenue Next 5Y3.68%
EBIT growth 1Y36.81%
EBIT growth 3Y31.06%
EBIT growth 5Y17.1%
EBIT Next Year63.27%
EBIT Next 3Y20.62%
EBIT Next 5Y15.69%
FCF growth 1Y403.43%
FCF growth 3Y-6.22%
FCF growth 5Y1.6%
OCF growth 1Y765.39%
OCF growth 3Y-2.15%
OCF growth 5Y3.17%

JENSEN-GROUP NV / JEN.BR FAQ

What is the fundamental rating for JEN stock?

ChartMill assigns a fundamental rating of 7 / 10 to JEN.BR.


What is the valuation status for JEN stock?

ChartMill assigns a valuation rating of 8 / 10 to JENSEN-GROUP NV (JEN.BR). This can be considered as Undervalued.


How profitable is JENSEN-GROUP NV (JEN.BR) stock?

JENSEN-GROUP NV (JEN.BR) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for JEN stock?

The Price/Earnings (PE) ratio for JENSEN-GROUP NV (JEN.BR) is 10.91 and the Price/Book (PB) ratio is 2.


How financially healthy is JENSEN-GROUP NV?

The financial health rating of JENSEN-GROUP NV (JEN.BR) is 8 / 10.